On March 7, 2023, Ms. Howson informed the Board of Directors of Cue Biopharma, Inc. of her intent to retire from the Board of Directors and not stand for re-election at the company's 2023 annual meeting of stockholders (the 2023 Annual Meeting). Ms. Howsons decision to retire from the Board of Directors and not stand for re-election did not involve any disagreement on any matter relating to the company's operations, policies or practices. Ms. Howson will continue to serve as a director until the 2023 Annual Meeting.

Ms. Howson is a member of the Compensation Committee and the Corporate Governance and Nominating Committee.